Brigham researchers develop an implantable device to detect and respond to opioid overdose
In preclinical models, the subcutaneously implanted device continuously monitored vital signs and delivered naloxone automatically and rapidly when it detected opioid overdose
The opioid epidemic continues to have devastating effects in the United States, exacerbated by the increasing presence of fentanyl in illicit opioids. Naloxone is an effective antidote, but it usually requires rapid administration from a bystander. Now, researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...










